Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 875 of 2529 entries
View as:

A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis

Phase: N/A Priority: Normal
NCT ID: NCT05646381 Org: User:
Start: 03/07/24 End: 03/12/30 Due: 03/12/31

Study of Pharmacokinetics, Activity and Safety of Ruxolitinib in Pediatric Patients With Grade II-IV Acute Graft vs. Host Disease

Phase: N/A Priority: Normal
NCT ID: NCT03491215 Org: User:
Start: 02/21/19 End: 02/02/23 Due: 02/02/24

Investigate Bioequivalence of Alpelisib Granule and Film-coated Tablet Formulation and the Food Effect of Alpelisib Granule Formulation in Adult Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05195892 Org: User:
Start: 02/03/22 End: 11/09/22 Due: 11/09/23

Dose Response Study of EMA401 in Patients With Post-herpetic Neuralgia (PHN)

Phase: N/A Priority: Normal
NCT ID: NCT03094195 Org: User:
Start: 06/27/17 End: 03/07/19 Due: 03/07/20

Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01275222 Org: User:
Start: 11/13/02 End: 09/03/08 Due: 09/03/09

A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD

Phase: N/A Priority: Normal
NCT ID: NCT01834885 Org: User:
Start: 12/31/13 End: 09/30/14 Due: 09/30/15

Impact of Secukinumab on Clinical and Patient Reported Outcomes in Patients With Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT05513014 Org: User:
Start: 03/21/21 End: 08/31/21 Due: 08/31/22

Efficacy and Safety of Bimagrumab/BYM338 at 52 Weeks on Physical Function, Muscle Strength, Mobility in sIBM Patients

Phase: N/A Priority: Normal
NCT ID: NCT01925209 Org: User:
Start: 09/26/13 End: 01/06/16 Due: 01/06/17

Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases)

Phase: N/A Priority: Normal
NCT ID: NCT00549757 Org: User:
Start: 10/31/07 End: 02/28/13 Due: 02/28/14

Study of Safety, Tolerability and Pharmacokinetics of Serelaxin in Japanese Acute Heart Failure (AHF) Patients

Phase: N/A Priority: Normal
NCT ID: NCT02002702 Org: User:
Start: 01/31/14 End: 08/31/14 Due: 08/31/15

Safety and Tolerability of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT01497262 Org: User:
Start: 02/29/12 End: 04/30/14 Due: 04/30/15

Oral Nilotinib in Adults With Chronic Myeloid Leukemia (CML) in Blast Crisis Who Are Imatinib Resistant or Intolerant

Phase: N/A Priority: Normal
NCT ID: NCT00413270 Org: User:
Start: 12/31/06 End: - Due: -

Open Label Extension to Bridging Study CTBM100C2303

Phase: N/A Priority: Normal
NCT ID: NCT00982930 Org: User:
Start: 08/12/09 End: 10/06/11 Due: 10/06/12

A First-in-human Study to Investigate the Safety, Tolerability and Pharmacokinetics of MAS825 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04665154 Org: User:
Start: 06/07/19 End: 08/03/22 Due: 08/03/23

ADCC Mediated B-Cell dEpletion and BAFF-R Blockade

Phase: N/A Priority: Normal
NCT ID: NCT03217422 Org: User:
Start: 02/15/18 End: 12/25/25 Due: 12/25/26

Safety and Tolerability of AIN457 in Adults (18-65 Years) With Moderate to Severe Ankylosing Spondylitis

Phase: N/A Priority: Normal
NCT ID: NCT01109940 Org: User:
Start: 04/30/10 End: 12/31/12 Due: 12/31/13

Efficacy and Safety of Valsartan/Amlodipine Compared to Amlodipine in Patients With Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00437645 Org: User:
Start: 01/31/07 End: 11/30/07 Due: 11/30/08

A Study to Determine the Absorption, Distribution, Metabolism, and Excretion of LBH589

Phase: N/A Priority: Normal
NCT ID: NCT00472368 Org: User:
Start: 05/31/07 End: - Due: -

A Prospective, Observational, Multicentre, 2 Year Study Evaluating the Use of Eylea (Aflibercept) for the Treatment of Neovascular (Wet) Age-related Macular Degeneration in UK NHS Opthalmology Clinics

Phase: N/A Priority: Normal
NCT ID: NCT02005133 Org: User:
Start: 11/30/13 End: 10/31/15 Due: 10/31/16

A Study to Evaluate the Effects of Indacaterol Maleate as a New Formulation in the Concept 1 Device

Phase: N/A Priority: Normal
NCT ID: NCT01484197 Org: User:
Start: 11/30/11 End: 05/31/12 Due: 05/31/13

Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT05541341 Org: User:
Start: 11/23/23 End: 11/23/43 Due: 11/23/44

PAtient RegisTry Assessing Effectiveness and Safety of HEart Failure treatmeNt With LCZ696 acrOss CaNada

Phase: N/A Priority: Normal
NCT ID: NCT02957409 Org: User:
Start: 05/20/16 End: 10/24/20 Due: 10/24/21

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Phase: N/A Priority: Normal
NCT ID: NCT01580020 Org: User:
Start: 05/31/12 End: 10/31/14 Due: 10/31/15

Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01716754 Org: User:
Start: 12/31/12 End: 01/31/16 Due: 01/31/17

Study of Efficacy and Safety of CVAA489 in Hypertensive Patients

Phase: N/A Priority: Normal
NCT ID: NCT02062645 Org: User:
Start: 02/28/14 End: 09/30/15 Due: 09/30/16